Virtual Medical Academy

Overview

Communicate Mounjaro value proposition and its use in day-to-day practice for people with type 2 Diabetes and Obesity.

This Activity for

Clinical Nutrition
Nursing and Midwifery
Resident / Fellow
Physician
Public and Community Health
Clinical Pharmacy

What I will learn?

• Discuss the latest guidelines and recommendations for obesity management from leading health organizations such as the American Diabetes Association (ADA) and the World Health Organization (WHO).

• Illustrate the appropriate patient selection criteria for new emerging weight management agents.

• Interpret the clinical data that supports the use of GIP/GLP-1 receptor agonists in treatment of type 2 diabetes especially in overweight patients.

• Describe the unique mechanism of action and dual benefits of GIP/GLP-1 receptor agonists in regulating blood glucose and managing weight, specifically for patients with type 2 diabetes.

• Interpret the latest updated guidelines and recommendations concerning the new emerging therapeutic agents that are indicated for regulating blood glucose and managing weight, specifically for patients with type 2 diabetes.

• Interpret the latest clinical trial data concerning safety and efficacy of new emerging therapeutic agents indicated for management of weight gain.